The protective effect of a newly developed molecular chaperone- inducer against mouse ischemic acute kidney injury

35Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Activation of the unfolded protein response (UPR) has been suggested to attenuate renal ischemia-reperfusion (I/R) injury. We recently found a compound, namely BIX, that activated the UPR selectively through the activating transcription factor 6 pathway. This study examined the effect of BIX on renal I/R injury in mice. BIX selectively up-regulated renal BiP mRNA and protein. Pretreatment with BIX significantly ameliorated renal I/R injury. Co- administration of BIX and tunicamycin, a non-selective UPR inducer, provided no additional protection. Our results suggest that the UPR activation by BIX leads to a novel drug therapy against renal I/R injury. © 2009 The Japanese Pharmacological Society.

Cite

CITATION STYLE

APA

Prachasilchai, W., Sonoda, H., Yokota-Ikeda, N., Ito, K., Kudo, T., Imaizumi, K., & Ikeda, M. (2009). The protective effect of a newly developed molecular chaperone- inducer against mouse ischemic acute kidney injury. Journal of Pharmacological Sciences, 109(2), 311–314. https://doi.org/10.1254/jphs.08272SC

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free